scholarly journals The MAZ transcription factor is a downstream target of the oncoprotein Cyr61/CCN1 and promotes pancreatic cancer cell invasion via CRAF–ERK signaling

2018 ◽  
Vol 293 (12) ◽  
pp. 4334-4349 ◽  
Author(s):  
Gargi Maity ◽  
Inamul Haque ◽  
Arnab Ghosh ◽  
Gopal Dhar ◽  
Vijayalaxmi Gupta ◽  
...  
2018 ◽  
Vol 454 (1-2) ◽  
pp. 87-95 ◽  
Author(s):  
Xin Li ◽  
Ming Dong ◽  
Jianping Zhou ◽  
Dehua Zhu ◽  
Jinbo Zhao ◽  
...  

2016 ◽  
Vol 5 (S6) ◽  
pp. S1093-S1097 ◽  
Author(s):  
Rémi Samain ◽  
Christine Jean ◽  
Corinne Bousquet

2001 ◽  
Vol 120 (5) ◽  
pp. A616
Author(s):  
Jiro Okami ◽  
Shoji Nakamori ◽  
Masato Sakon ◽  
Hirofumi Yamamoto ◽  
Nobuaki Hiraok ◽  
...  

2002 ◽  
Vol 122 (2) ◽  
pp. 308-317 ◽  
Author(s):  
Toshiyuki Kusama ◽  
Mutsuko Mukai ◽  
Teruo Iwasaki ◽  
Masaharu Tatsuta ◽  
Yoshirou Matsumoto ◽  
...  

Cancer ◽  
2007 ◽  
Vol 109 (9) ◽  
pp. 1811-1820 ◽  
Author(s):  
Sarah K. Johnson ◽  
Vishnu C. Ramani ◽  
Leah Hennings ◽  
Randy S. Haun

2015 ◽  
Vol 15 (1) ◽  
Author(s):  
Xu Ying ◽  
Li Jing ◽  
Shijie Ma ◽  
Qianjun Li ◽  
Xiaoling Luo ◽  
...  

eLife ◽  
2021 ◽  
Vol 10 ◽  
Author(s):  
Akikazu Harada ◽  
Shinji Matsumoto ◽  
Yoshiaki Yasumizu ◽  
Toshiyuki Akama ◽  
Hidetoshi Eguchi ◽  
...  

Pancreatic cancer has a high mortality rate due to metastasis. Whereas KRAS is mutated in most pancreatic cancer patients, controlling KRAS or its downstream effectors has not been succeeded clinically. ARL4C is a small G protein whose expression is induced by the Wnt and EGF-RAS pathways. In the present study, we found that ARL4C is frequently overexpressed in pancreatic cancer patients and showed that its localization to invasive pseudopods is required for cancer cell invasion. IQGAP1 was identified as a novel interacting protein for ARL4C. ARL4C recruited IQGAP1 and its downstream effector, MMP14, to invasive pseudopods. Specific localization of ARL4C, IQGAP1, and MMP14 was the active site of invasion, which induced degradation of the extracellular matrix. Moreover, subcutaneously injected antisense oligonucleotide against ARL4C into tumor-bearing mice suppressed metastasis of pancreatic cancer. These results suggest that ARL4C-IQGAP1-MMP14 signaling is activated at invasive pseudopods of pancreatic cancer cells.


Sign in / Sign up

Export Citation Format

Share Document